Skip to content
ClinCalc Pro
Menu
Bowel preparation component

Citric acid

Citric acid is a weak organic acid used in various preparations; in combination products it acidifies the urine or, with potassium/sodium citrate, alkalinises it, and it is also used to dissolve catheter encrustation as a bladder irrigation.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It acts as a buffering agent and, depending on the salt with which it is combined, modifies urinary pH; as a chelating irrigation it helps dissolve calcium and struvite deposits.

Prescribing in practice

  • Confirm the intended preparation and indication, as citric acid appears in many different formulations (oral acidifying mixtures, alkalinising citrate salts, and bladder irrigations) that are not interchangeable.
  • Oral citrate combinations contain sodium or potassium and should be used cautiously where there is cardiac, renal or electrolyte concern; check the SPC for the specific product.
  • Avoid concomitant use that would inappropriately alter urinary pH against the therapeutic aim and review interacting medicines whose elimination is pH-dependent.

Monitoring

Monitor urinary pH where the aim is to acidify or alkalinise, and check serum electrolytes when sodium- or potassium-containing citrate preparations are used.

Counselling the patient

  • Take oral preparations diluted in water as directed.
  • Report any swelling, breathlessness or palpitations promptly.
  • Use the specific product prescribed and do not substitute.

Evidence & guidelines

Use is long established and reflected in current prescribing references and the relevant SPCs rather than in large randomised trials.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.